| Application number | Title of the application | Filing Date | Status |
|---|
| 08/781745 | TRANSITION - STATE INHIBITORS FOR NUCLEOSIDE HYDROLASE AND TRANSFERASE REACTIONS | Jan 9, 1997 | Abandoned |
Array
(
[id] => 3768911
[patent_doc_number] => 05773390
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Chemical additive for removing solids from a well drilling system'
[patent_app_type] => 1
[patent_app_number] => 8/780317
[patent_app_country] => US
[patent_app_date] => 1997-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5484
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773390.pdf
[firstpage_image] =>[orig_patent_app_number] => 780317
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/780317 | Chemical additive for removing solids from a well drilling system | Jan 7, 1997 | Issued |
Array
(
[id] => 3726592
[patent_doc_number] => 05681977
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Method for the production of (3-alkoxycarbonyl-2-butenyl) triphenylphosphonium salts'
[patent_app_type] => 1
[patent_app_number] => 8/779785
[patent_app_country] => US
[patent_app_date] => 1997-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7770
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681977.pdf
[firstpage_image] =>[orig_patent_app_number] => 779785
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/779785 | Method for the production of (3-alkoxycarbonyl-2-butenyl) triphenylphosphonium salts | Jan 6, 1997 | Issued |
| 08/779778 | C-TEMINAL KETONE INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF(ALPHA) SECRETION | Jan 6, 1997 | Abandoned |
Array
(
[id] => 3775664
[patent_doc_number] => 05756753
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Methine and azamethine dyes based on naphthoquinones in nonlinear optics'
[patent_app_type] => 1
[patent_app_number] => 8/750846
[patent_app_country] => US
[patent_app_date] => 1996-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2890
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756753.pdf
[firstpage_image] =>[orig_patent_app_number] => 750846
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/750846 | Methine and azamethine dyes based on naphthoquinones in nonlinear optics | Dec 23, 1996 | Issued |
Array
(
[id] => 3772084
[patent_doc_number] => 05756522
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Triazole derivatives and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/772086
[patent_app_country] => US
[patent_app_date] => 1996-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20077
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756522.pdf
[firstpage_image] =>[orig_patent_app_number] => 772086
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/772086 | Triazole derivatives and uses thereof | Dec 19, 1996 | Issued |
Array
(
[id] => 3733968
[patent_doc_number] => 05693820
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Ruthenium complexes with a chiral, bidentate phosphine/oxazoline ligand for enantioselective transfer hydrogenation of prochiral ketones'
[patent_app_type] => 1
[patent_app_number] => 8/777743
[patent_app_country] => US
[patent_app_date] => 1996-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3533
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 455
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693820.pdf
[firstpage_image] =>[orig_patent_app_number] => 777743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/777743 | Ruthenium complexes with a chiral, bidentate phosphine/oxazoline ligand for enantioselective transfer hydrogenation of prochiral ketones | Dec 19, 1996 | Issued |
Array
(
[id] => 4014127
[patent_doc_number] => 05880121
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => '4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof'
[patent_app_type] => 1
[patent_app_number] => 8/769343
[patent_app_country] => US
[patent_app_date] => 1996-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7850
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880121.pdf
[firstpage_image] =>[orig_patent_app_number] => 769343
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/769343 | 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof | Dec 18, 1996 | Issued |
Array
(
[id] => 3933843
[patent_doc_number] => 05939418
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-17
[patent_title] => 'Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/768908
[patent_app_country] => US
[patent_app_date] => 1996-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37028
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/939/05939418.pdf
[firstpage_image] =>[orig_patent_app_number] => 768908
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/768908 | Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors | Dec 16, 1996 | Issued |
| 08/771339 | PHARMACEUTICAL COMPOUNDS | Dec 15, 1996 | Abandoned |
Array
(
[id] => 3628733
[patent_doc_number] => 05686452
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Indane derivative and processes for preparing the same'
[patent_app_type] => 1
[patent_app_number] => 8/767392
[patent_app_country] => US
[patent_app_date] => 1996-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4965
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686452.pdf
[firstpage_image] =>[orig_patent_app_number] => 767392
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/767392 | Indane derivative and processes for preparing the same | Dec 15, 1996 | Issued |
Array
(
[id] => 3665357
[patent_doc_number] => 05668164
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds'
[patent_app_type] => 1
[patent_app_number] => 8/764418
[patent_app_country] => US
[patent_app_date] => 1996-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7361
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/668/05668164.pdf
[firstpage_image] =>[orig_patent_app_number] => 764418
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/764418 | Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds | Dec 11, 1996 | Issued |
Array
(
[id] => 3787937
[patent_doc_number] => 05736564
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Endothelin receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/464761
[patent_app_country] => US
[patent_app_date] => 1996-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 867
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736564.pdf
[firstpage_image] =>[orig_patent_app_number] => 464761
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464761 | Endothelin receptor antagonists | Dec 11, 1996 | Issued |
Array
(
[id] => 3872450
[patent_doc_number] => 05763471
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Melatoninergic agonist spiro ›indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products'
[patent_app_type] => 1
[patent_app_number] => 8/722105
[patent_app_country] => US
[patent_app_date] => 1996-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10225
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 344
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763471.pdf
[firstpage_image] =>[orig_patent_app_number] => 722105
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/722105 | Melatoninergic agonist spiro ›indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products | Dec 10, 1996 | Issued |
Array
(
[id] => 3730490
[patent_doc_number] => 05670640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-23
[patent_title] => 'Process for the manufacture of imidazodiazepine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/762632
[patent_app_country] => US
[patent_app_date] => 1996-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2790
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/670/05670640.pdf
[firstpage_image] =>[orig_patent_app_number] => 762632
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/762632 | Process for the manufacture of imidazodiazepine derivatives | Dec 8, 1996 | Issued |
Array
(
[id] => 4143727
[patent_doc_number] => 06030991
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Benzenesulfonamides and the use thereof to modulate the activity of endothelin'
[patent_app_type] => 1
[patent_app_number] => 8/730633
[patent_app_country] => US
[patent_app_date] => 1996-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36543
[patent_no_of_claims] => 125
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/030/06030991.pdf
[firstpage_image] =>[orig_patent_app_number] => 730633
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/730633 | Benzenesulfonamides and the use thereof to modulate the activity of endothelin | Dec 5, 1996 | Issued |
Array
(
[id] => 3771870
[patent_doc_number] => 05756507
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Antagonists of gonadotropin releasing hormone'
[patent_app_type] => 1
[patent_app_number] => 8/760851
[patent_app_country] => US
[patent_app_date] => 1996-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27594
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1751
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756507.pdf
[firstpage_image] =>[orig_patent_app_number] => 760851
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/760851 | Antagonists of gonadotropin releasing hormone | Dec 4, 1996 | Issued |
Array
(
[id] => 3748786
[patent_doc_number] => 05717108
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-10
[patent_title] => 'Process for the preparation of indole compounds'
[patent_app_type] => 1
[patent_app_number] => 8/759648
[patent_app_country] => US
[patent_app_date] => 1996-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1657
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/717/05717108.pdf
[firstpage_image] =>[orig_patent_app_number] => 759648
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/759648 | Process for the preparation of indole compounds | Dec 4, 1996 | Issued |
Array
(
[id] => 3748657
[patent_doc_number] => 05717097
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-10
[patent_title] => 'HIV protease inhibitors useful for the treatment of AIDS'
[patent_app_type] => 1
[patent_app_number] => 8/759203
[patent_app_country] => US
[patent_app_date] => 1996-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18479
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/717/05717097.pdf
[firstpage_image] =>[orig_patent_app_number] => 759203
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/759203 | HIV protease inhibitors useful for the treatment of AIDS | Dec 3, 1996 | Issued |
Array
(
[id] => 3732165
[patent_doc_number] => 05665714
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-09
[patent_title] => 'N-substituted glycerophosphoethanolamines'
[patent_app_type] => 1
[patent_app_number] => 8/758934
[patent_app_country] => US
[patent_app_date] => 1996-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8387
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/665/05665714.pdf
[firstpage_image] =>[orig_patent_app_number] => 758934
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/758934 | N-substituted glycerophosphoethanolamines | Dec 2, 1996 | Issued |